Abstract | BACKGROUND: Data on independent risk factors for stroke recurrence in Japanese patients with nonvalvular atrial fibrillation are limited. METHODS: RESULTS: Patients in the secondary prevention group (1101 of 6306 patients [17.5%] analyzed; mean observation period, 15.7 months) had a higher risk of ischemic stroke or hemorrhage than those in the primary prevention group. The incidence rates of major (3.92%/year vs 2.06%/year), intracranial (1.87%/year vs 0.55%/year), and cerebral (1.14%/year vs 0.37%/year) hemorrhage and effectiveness outcomes ( ischemic stroke/systemic embolism/ transient ischemic attack, 3.25%/year vs 0.57%/year) were significantly higher (all P < 0.001) in the secondary prevention group than in the primary prevention group. Multivariate analysis identified no independent risk factors in the secondary prevention group, while prior major bleeding, alcohol abuse, advanced age, male sex, lower body weight, higher serum creatinine, and antiplatelet drug use were identified as risk factors for major hemorrhage, and advanced age and antiplatelet drug use for effectiveness outcomes in the primary prevention group. CONCLUSIONS:
|
Authors | Masahiro Yasaka, Michiaki Umeyama, Hirohide Kataoka, Hiroshi Inoue |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 29
Issue 9
Pg. 105034
(Sep 2020)
ISSN: 1532-8511 [Electronic] United States |
PMID | 32807446
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Observational Study)
|
Copyright | Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Factor Xa Inhibitors
- Pyrazoles
- Pyridones
- apixaban
|
Topics |
- Aged
- Aged, 80 and over
- Atrial Fibrillation
(diagnosis, drug therapy, epidemiology)
- Factor Xa Inhibitors
(administration & dosage, adverse effects)
- Female
- Hemorrhage
(chemically induced)
- Humans
- Incidence
- Ischemic Attack, Transient
(diagnosis, epidemiology, prevention & control)
- Japan
(epidemiology)
- Male
- Middle Aged
- Primary Prevention
- Product Surveillance, Postmarketing
- Prospective Studies
- Pyrazoles
(administration & dosage, adverse effects)
- Pyridones
(administration & dosage, adverse effects)
- Recurrence
- Risk Assessment
- Risk Factors
- Secondary Prevention
- Stroke
(diagnosis, epidemiology, prevention & control)
- Time Factors
- Treatment Outcome
|